← Leaderboards
Stephanie J Bissel
University Of Pittsburgh At Pittsburgh
$2,261,540
Attributed
$6,784,621
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2012–25$2.5M$1.9M$1.3M$625K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,784,621 · 3
By mechanism
R01$4,450,947 · 2
RF1$2,333,674 · 1
Top collaborators
- Charles W Bradberry5 shared
- Clayton A. Wiley5 shared
- Bruce T Lamb3 shared
- Gary E. Landreth3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Clayton A. Wiley$13,389,430
- Corina Oana Bondi$3,044,572
- Cristian L Achim$16,124,362
- Howard J Aizenstein$23,319,766
- Milos D Ikonomovic$11,868,106
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposComplexInvestigationPerformanceNeurodegenerative DisordersBrainPathway InteractionsPathogenesisTau ProteinsBehavioralLinkMapsAmyloid Beta-ProteinAge RelatedAge GroupAcquired Immunodeficiency SyndromeBehavior MeasurementCd4 Lymphocyte CountAging-Related ProcessAging BrainAstrocytosisAutopsyAids Dementia ComplexAged
Grant awards (8)
Impact of PLCG2 Alzheimer's Disease Risk Variants on Microglia Biology and Disease Pathogenesis$730,718
R01 · FY2025 · AG
Impact of PLCG2 Alzheimer's Disease Risk Variants on Microglia Biology and Disease Pathogenesis$753,556
R01 · FY2024 · AG
Impact of PLCG2 Alzheimer's Disease Risk Variants on Microglia Biology and Disease Pathogenesis$2,333,674
RF1 · FY2021 · AG
Neurodegeneration in Aged SIV-Infected Primates$577,660
R01 · FY2016 · MH
Neurodegeneration in Aged SIV-Infected Primates$641,262
R01 · FY2015 · MH
Neurodegeneration in Aged SIV-Infected Primates$638,556
R01 · FY2014 · MH
Neurodegeneration in Aged SIV-Infected Primates$580,627
R01 · FY2013 · MH
Neurodegeneration in Aged SIV-Infected Primates$528,568
R01 · FY2012 · MH